HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ran-Ran Ma Selected Research
Ran-Ran Ma Research Topics
Disease
11
Stomach Neoplasms (Stomach Cancer)
11/2023 - 04/2015
9
Neoplasm Metastasis (Metastasis)
01/2022 - 04/2015
6
Neoplasms (Cancer)
01/2021 - 04/2015
3
Lymphatic Metastasis
01/2023 - 03/2019
3
Breast Neoplasms (Breast Cancer)
01/2020 - 10/2017
1
Carcinoma (Carcinomatosis)
11/2023
1
Hepatocellular Carcinoma (Hepatoma)
07/2016
1
Diabetic Retinopathy (Retinopathy, Diabetic)
01/2014
1
Type 2 Diabetes Mellitus (MODY)
01/2014
Drug/Important Bio-Agent (IBA)
4
Long Noncoding RNA
IBA
11/2023 - 10/2018
4
MicroRNAs (MicroRNA)
IBA
01/2020 - 11/2015
4
Biomarkers (Surrogate Marker)
IBA
01/2020 - 04/2015
3
Messenger RNA (mRNA)
IBA
01/2023 - 03/2019
3
Proteins (Proteins, Gene)
FDA Link
01/2021 - 04/2015
1
RNA (Ribonucleic Acid)
IBA
11/2023
1
lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)
IBA
01/2022
1
DNA (Deoxyribonucleic Acid)
IBA
01/2022
1
Kinesins
IBA
01/2021
1
70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)
IBA
01/2020
1
Competitive Endogenous RNA
IBA
01/2020
1
Indicators and Reagents (Reagents)
IBA
03/2019
1
Antigens
IBA
03/2019
1
Odorant Receptors (Odorant Receptor)
IBA
01/2019
1
Hepatocyte Nuclear Factor 1
IBA
10/2018
1
Untranslated RNA (Noncoding RNA)
IBA
10/2018
1
Antisense RNA (Anti-Sense RNA)
IBA
10/2018
1
Serine Proteases (Serine Protease)
IBA
04/2017
1
Peptide Hydrolases (Proteases)
FDA Link
04/2017
1
Cadherins (E-Cadherin)
IBA
04/2017
1
Glypicans
IBA
07/2016
1
Vascular Endothelial Growth Factor C
IBA
11/2015
1
Carrier Proteins (Binding Protein)
IBA
04/2015
1
Elements
IBA
04/2015
1
apelin-13 peptide
IBA
01/2014
1
Retinaldehyde (Retinal)
IBA
01/2014
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2014
1
G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
IBA
01/2014
1
Ligands
IBA
01/2014
Therapy/Procedure
3
Therapeutics
01/2022 - 10/2017